Record Keeping is of vital importance to the regulated cannabis industry because it supports various important functions including making or breaking Health Canada inspections. Documentation is the legal proof that work was adequately performed and provides a written history of company and products, as well proving to regulators that the company follows its regulatory commitments. Retention periods for the cannabis industry can be up to 25 years for some records, therefore they must be appropriately protected whether it be on or off site.
Mr. Steven Tanner has worked for and partnered (GQRP) with the top global pharmaceutical manufacturing, contract research, wholesale and specialty distribution organizations in both Europe and North America. From Eli Lilly UK to Merck KGaA (now Mylan) in Canada, Pharmanet (now Inventiv Health), Teva, and the McKesson Corporation, Steven now surpasses more than 18-years of progressive GxP industry experience in quality, compliance and technical training senior leadership roles.
Steven’s specialties include leading FDA and Health Canada GMP inspections, customer 3rd party logistics (3PL) quality & qualification audits, as well as the hands-on design, strategy, execution and management of GxP regulatory quality systems: change controls, deviation controls, CAPA, validation/21 CFR Part 11, document controls, environmental monitoring, complaints, equipment & shipment qualifications, SOPs, technical writing, drug recalls, quality agreements, self-inspections. Steven has also partnered since 2004 with AAPS – Academy of Applied Pharmaceutical Sciences where he’s provided quality assurance/GxP technical facilitation. In 2016 Steven accepted a full-time role as Campus Manager and Director of Student Affairs with AAPS.
Steven graduated in 1999 with an honours degree in Chemistry from Leicester University in the United Kingdom and holds a postgraduate diploma in Adult Education from St Francis Xavier University, Nova Scotia, Canada.
This webinar examines the history, rationale, purpose, and application of ACMPR – Access to Cannabis for Medical Purposes Regulations GPP Good Production Practice requirements applicable to the cannabis industry and consequences of inaction.
Gain practical knowledge in understanding of the essential elements and quality systems required for ACMPR GPP and for maintaining compliance in the marihuana industry.
Analytical Tests, Microbial and chemical contaminants and pest control products
Sanitation Program – Premise, Equipment, Personnel
Standard Operating Procedures
Recall and Recall Reporting
Adverse Reactions and Adverse Reactions Reporting
Who Should Attend:
This course is valuable for Directors, Managers, Supervisors and Associates in the medical cannabis industry with daily responsibilities in the following areas:
Documentation and Technical Writing
For more information please visit: www.aaps.ca
The place of cannabis marijuana in the lives of Canadians will undergo a radical change with its legalization and entry into the mainstream.
This transformation will affect Canada’s legal landscape, and the new status of cannabis will have profound implications in many areas of practice including (but not limited to): civil litigation, criminal law, municipal law, health law, insurance law, labour and employment law, business law, and corporate finance.
If you practice in an area of law which has a significant cannabis marijuana dimension, you need this program!
- Receive an overview including cannabis marijuana basics (botany and pharmacology), the history of cannabis in Canada and globally, the proposed federal Cannabis Act and regulations, the proposed BC regulations, and the impact on local government.
- “Cannabis as Medicine”: examine the evolution of cannabis marijuana from a controlled drug to a regulated health care product, as well as the current issues in discourse surrounding medical cannabis.
- “Cannabis and Impairment”: explore the twin issues of regulation and measurement of potential impairment caused by cannabis in both the criminal law and employment law contexts.
- “Cannabis and Business—The Ultimate Joint Venture”: review the major issues that arise when advising cannabis-related business including business regulation, investment and finance, insurance, and cross-border issues.
The Government of Canada has indicated that it intends to bring the proposed Cannabis Act into force no later than July 2018. To support implementation of the proposed Act, regulations would need to be enacted in a range of areas, such as cannabis product standards and packaging and labelling requirements, to ensure that the risks and harms of cannabis are appropriately addressed under the legal framework.
In many cases, Health Canada is proposing to build upon established regulatory requirements that have been in place under ACMPR. This webinar aims to summarize the proposed changes from the current ACMPR regulation and to provide an understanding of “proposed Cannabis Act”.
Canada will become the first G-20 country in the world to legalize cannabis next July, and few companies are positioned as well as Canopy Growth, which has leading market share in its medical cannabis market. While the company is driving full-speed ahead to capitalize on legalization in Canada, it has pursued several international ventures as well that it expects will ultimately create the most value for shareholders. Join Canopy Growth CEO Bruce Linton as he discusses the company’s global opportunities across four continents and then takes questions from participants in this exclusive, limited seating webinar!